Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00859859 · ClinicalTrials.gov registry record · Phase 1
Vagus Nerve Stimulation in Rheumatoid Arthritis
A Phase 1 study, sponsored by Northwell Health.
- Terminated
- Registry status
- Phase 1
- Development phase
- 23
- Enrollment target
NCT00859859 is a Phase 1 study that was terminated before completion, run by Northwell Health. The registered enrollment target is 23 participants.
The verdict
NCT00859859, a Phase 1 study, was terminated before completion, sponsored by Northwell Health.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 23 participants
- Enrollment target
Study Summary
The purpose of this study is to examine the short-term effects of vagus nerve stimulation (VNS) by auricular stimulation (stimulation of the auricular branch of the vagus nerve which innervates the ear) in rheumatoid arthritis (RA). RA is characterized by a chronic systemic inflammation affecting the joints but also carries an increased risk for extra-articular manifestations as well as other organ manifestations such as cardiovascular disease (CVD), which significantly contributes to morbidity and mortality in this disorder.
Interventions
- DEVICE Vagus Nerve Stimulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2006-10 |
| Est. Completion | 2009-02 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00859859
The ClinicalTrials.gov registry entry for NCT00859859 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwell Health, which has 370 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Vagus Nerve Stimulation is the first listed.
NCT00859859 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00859859 about?
NCT00859859 is a clinical study titled "Vagus Nerve Stimulation in Rheumatoid Arthritis". The purpose of this study is to examine the short-term effects of vagus nerve stimulation (VNS) by auricular stimulation (stimulation of the auricular branch of the vagus nerve which innervates the ear) in rheumatoid arthritis (RA). RA is characterized by a chronic systemic inflammation affecting th...
What is the current status of trial NCT00859859?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 23 participants. The study started on 2006-10. Estimated completion is 2009-02.
What interventions are being tested in trial NCT00859859?
The interventions under investigation include: Vagus Nerve Stimulation (DEVICE).
Who is sponsoring clinical trial NCT00859859?
This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.